Paz Ocaranza M, Riquelme JA, García L, Jalil JE, Chiong M, Santos RAS, Lavandero S. Counter-regulatory renin-angiotensin system in cardiovascular disease. Nat Rev Cardiol. 2020;17:116–29.

Article  PubMed  Google Scholar 

Silva GM, França-Falcão MS, Calzerra NTM, Luz MS, Gadelha DDA, Balarini CM, Queiroz TM. Role of renin-angiotensin System Components in Atherosclerosis: Focus on Ang-II, ACE2, and Ang-1-7. Front Physiol. 2020;11:1067.

Article  PubMed  PubMed Central  Google Scholar 

R C SM. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull (British medical bulletin). 1994;50:278–98.

Google Scholar 

Slivnick J, Lampert BC. Hypertension and heart failure. Heart Fail Clin. 2019;15:531–41.

Article  PubMed  Google Scholar 

Frąk W, Wojtasińska A, Lisińska W, Młynarska E, Franczyk B, Rysz J. Pathophysiology of Cardiovascular Diseases: New Insights into Molecular Mechanisms of Atherosclerosis, Arterial Hypertension, and Coronary Artery Disease.Biomedicines2022,10.

Tiret L, Bonnardeaux A, Poirier O, Ricard S, Marques-Vidal P, Evans A, Arveiler D, Luc G, Kee F, Ducimetiere P, et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet. 1994;344:910–3.

Article  CAS  PubMed  Google Scholar 

Bonnardeaux A, Davies E, Jeunemaitre X, Fery I, Charru A, Clauser E, Tiret L, Cambien F, Corvol P, Soubrier F. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension. 1994;24:63–9.

Article  CAS  PubMed  Google Scholar 

Cuspidi C, Tadic M, Grassi G, Mancia G. Treatment of hypertension: the ESH/ESC guidelines recommendations. Pharmacol Res. 2018;128:315–21.

Article  PubMed  Google Scholar 

Mancia G. The new american guidelines on hypertension: a favorable opinion. J Clin Hypertens (Greenwich). 2014;16:255–6.

Article  PubMed  Google Scholar 

Fredman L, Sexton M, Cui Y, Althuis M, Wehren L, Hornbeck P, Kanarek N. Cigarette smoking, alcohol consumption, and screening mammography among women ages 50 and older. Prev Med. 1999;28:407–17.

Article  CAS  PubMed  Google Scholar 

Arslan F, Bongartz L, Ten Berg JM, Jukema JW, Appelman Y, Liem AH, de Winter RJ, van ‘t Hof AWJ, Damman P. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: comments from the dutch ACS working group. Neth Heart J. 2018;26:417–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)developed with the special contribution of the heart failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129–200.

Article  PubMed  Google Scholar 

Bao L, Zhuomin L, Yunqian L. Comparison of coronary angiography and three kinds of noninvasive methods in the diagnosis of coronary artery disease. Chin J cardiovscular. 1999;27:105–6.

Google Scholar 

Wu C-K, Tsai C-T, Chang Y-C, Luo J-L, Wang Y-C, Hwang J-J, Lin J-L, Tseng C-D, Chiang F-T. Genetic polymorphisms of the angiotensin II type 1 receptor gene and diastolic heart failure.Journal of Hypertension2009,27.

Jin-jun R, Yuan J, Qiao-lan L. Meta-analysis on the risks factors of coronary heart diease. Med J west china. 2014;26:1629–32.

Google Scholar 

Lino CA, Barreto-Chaves ML. Beta-arrestins in the context of cardiovascular diseases: focusing on angiotensin II type 1 receptor (AT1R). Cell Signal. 2022;92:110253.

Article  CAS  PubMed  Google Scholar 

Hypertension WGoCGftMo, League CH, Cardiology CSo, Committee CMDAH, Care, HBoCIEaPAfMaH. Association HBoCGM: 2018 Chinese guidelines for the management of hypertension.Chinese Journal of Cardiovascular Medicine2019,24.

Sanchis-Gomar F, Perez-Quilis C, Leischik R, Lucia A. Epidemiology of coronary heart disease and acute coronary syndrome.Ann Trans Med2016,4.

Miao B, Hernandez AV, Alberts MJ, Mangiafico N, Roman YM, Coleman CI. Incidence and predictors of major adverse cardiovascular events in patients with established atherosclerotic disease or multiple risk factors. J Am Heart Association(J Am Heart Assoc). 2020;9:e014402.

Article  CAS  PubMed  Google Scholar 

Wong Y-K, Cheung CY, Tang CS, Au K-W, Hai JS, Lee C-H, Lau K-K, Cheung BM, Sham P-C, Xu A. Age-biomarkers-clinical risk factors for prediction of cardiovascular events in patients with coronary artery disease. Arteriosclerosis, Thrombosis,Vascular Biology(Arterioscler Thromb V asc Biol) 2018, 38:2519–2527.

zhang j. The characteristics of blood pressure and its relationship with the incidence of Cardiovascular Event in patients with essential hypertension combining Coronary Heart Disease. Chin J Integr Med cardiovscular disease. 2009;7:141–3.

Google Scholar 

Jespersen L, Hvelplund A, Abildstrøm SZ, Pedersen F, Galatius S, Madsen JK, Jørgensen E, Kelbæk H, Prescott E. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J. 2011;33:734–44.

Article  PubMed  Google Scholar 

Cao X, Kang Y, Tian Y, Wang X, Chen Z, Zhang L, Zheng C, Chen L, Zhou H, Wang Z. Attributable risk of cardiovascular mortality associated with different glycometabolic status among different regions in China. Chin J Cardiovasc Med. 2022;27:60–5.

Google Scholar 

Xuehui J, Lixia G, Beiyan Z, Yujin T. The influence of heart rate variability on the prognosis of elderly patients with heart failure.Chinese Journal of Cardiovascular Medicine2022,27.

Keith M, Diaz, Tanner RM, Falzon L, Levitan EB, Reynolds K, Shimbo D, Muntner P. Visit-to-visit variability of blood pressure and cardiovascular disease and all-cause mortality: a systematic review and meta-analysis. Hypertension. 2014;64:965–82.

Article  Google Scholar 

Gosmanova EO, Mikkelsen MK, Molnar MZ, Lu JL, Yessayan LT, Kalantar-Zadeh K, Kovesdy CP. Association of systolic blood pressure variability with mortality,Coronary Heart Disease, Stroke,and Renal Disease. J Am Coll Cardiol. 2016;68:1375–86.

Article  PubMed  PubMed Central  Google Scholar 

Boey E, Gay GMW, Poh K-K, Yeo T-C, Tan H-C, Lee C-H. Visit-to-visit variability in LDL- and HDL-cholesterol is associated with adverse events after ST-segment elevation myocardial infarction: a 5-year follow-up study. Atherosclerosis. 2016;244:86–92.

Article  CAS  PubMed  Google Scholar 

Liu C, Li Y, Guan T, Lai Y, Shen Y, Zeyaweiding A, Zhao H, Li F, Maimaiti T. ACE2 polymorphisms associated with cardiovascular risk in uygurs with type 2 diabetes mellitus. Cardiovasc Diabetol. 2018;17:127.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Y, Li X, Jia N, Guo S, Chu S, Niu W. Meta-analysis of the association between angiotensin II receptor, type 1 gene A1166C polymorphism and coronary artery disease in chinese populations. J Renin-Angiotensin-Aldosterone Syst. 2013;14:82–90.

Article  PubMed  Google Scholar 

Kumar R, Singh VP, Baker KM. The intracellular renin–angiotensin system: implications in cardiovascular remodeling. Curr Opin Nephrol Hypertens. 2008;17:168–73.

Article  CAS  PubMed  Google Scholar 

N D-Y PP, FW P. Overexpression of angiotensin I type I receptor in cardiomyocytes induces cardiachypertrophy and remodeling.Proc Natl Acad Sei U S A2000:931–936.

Paradis P, Dali-Youcef N, Paradis FW, Thibault Gt, Nemer M. Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling. The Proceedings of the National Academy of Sciences 2000, 97:931–936.

C A, F MHCB, N R, Lablanche HEPMXE. The angiotensin II type 1 receptor gene polymorphism is AssociatedWith coronary artery vasoconstriction. J Am Coll Cardiol. 1997;29:486–90.

Article  Google Scholar 

Gai MT, Ma YT, Yang YN, Liu F, Xie X, Li XM, Ma X, Fu ZY, Chen BD, Chen XC. [Current status regarding the cardiovascular disease-related risk levels among the hypertensive population of different ethnicities in Xinjiang Uygur Autonomous Region, China]. Zhonghua Yi Xue Za Zhi. 2016;96:565–9.

CAS  PubMed  Google Scholar 

Wang YT, Tao J, Maimaiti A, Adi D, Yang YN, Li XM, Ma X, Liu F, Chen BD, Ma YT. Prevalence of valvular heart diseases and associated risk factors in Han, Uygur and Kazak population in Xinjiang, China. PLoS ONE. 2017;12:e0174490.

Article  PubMed  PubMed Central  Google Scholar 

Yang YN, Ma YT, Liu F, Huang D, Li XM, Huang Y, Tang Q, Chen BD, Ma X, Xie X, et al. [Incidence and distributing feature of chronic heart failure in adult population of Xinjiang]. Zhonghua xin xue guan bing za zhi. 2010;38:460–4.

PubMed  Google Scholar 

Chen P, Ma YT, Yang YN, Liu F, Huang D, Li XM, Huang Y, Ma X, Xie X, Yang SJ, Yu ZX. [Prevalence of peripheral arterial disease and its correlative risk factors in Xinjiang Uygur and Kazak adult populations]. Zhonghua Yi Xue Za Zhi. 2010;90:3115–8.

PubMed  Google Scholar 

Feng X, Zheng B-S, Shi J-J, Qian J, He W, Zhou H-F. A systematic review and meta-analysis of the association between angiotensin II type 1 receptor A1166C gene polymorphism and myocardial infarction susceptibility. J Renin-Angiotensin-Aldosterone Syst. 2014;15:307–15.

Article  CAS  PubMed  Google Scholar 

Zhang H, Sun M, Peng J, Sun T, Zhang Y, Yang J. Association of the angiotensin type 1 receptor gene A1166C polymorphisms with myocardial infarction: a meta-analysis. J Thromb haemostasis. 2011;9:1258–60.

Article  CAS  Google Scholar 

Shuyao W, Yan L, Qian S. Multivariate analysis of risk and prognostic factors in patients with Coronary Heart Disease. Chin Gen Pract. 2018;21:3562–70.

Google Scholar